Application 210221
- Type
- ANDA
- Sponsor
- ALKEM LABS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CEPHALEXIN | CEPHALEXIN | FOR SUSPENSION;ORAL | EQ 125MG BASE/5ML | No | No |
| 002 | CEPHALEXIN | CEPHALEXIN | FOR SUSPENSION;ORAL | EQ 250MG BASE/5ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A210221-001 | CEPHALEXIN | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | |
| A210221-002 | CEPHALEXIN | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A210221-001 | AB |
| A210221-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A210221-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A210221-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A210221-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A210221-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A210221-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A210221-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210221-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210221-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A210221-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A210221-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210221-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210221-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210221-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210221-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210221-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210221-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A210221-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A210221-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A210221-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A210221-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A210221-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A210221-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A210221-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A210221-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A210221-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A210221-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A210221-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A210221-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A210221-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A210221-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A210221-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A210221-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A210221-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A210221-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A210221-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A210221-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A210221-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A210221-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A210221-001 | CEPHALEXIN | EQ 125MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A210221-002 | CEPHALEXIN | EQ 250MG BASE/5ML | FOR SUSPENSION / ORAL | AB | 2019-03-26 | 74a2ff9319b5… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-03-09 01:35 UTC | 2022-03 | A210221-001 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A210221-002 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A210221-001 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A210221-002 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A210221-001 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A210221-002 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A210221-001 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A210221-002 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A210221-001 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A210221-002 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A210221-001 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A210221-002 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A210221-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A210221-002 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A210221-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A210221-002 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A210221-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A210221-002 | AB | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A210221-001 | AB | 1 | 6a51e52b5d6a… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A210221-002 | AB | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A210221-001 | AB | 1 | 1c564ffb4f44… |
| 2024-02-18 07:12 UTC | 2024-02 | A210221-002 | AB | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A210221-001 | AB | 1 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | A210221-002 | AB | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A210221-001 | AB | 1 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A210221-002 | AB | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A210221-001 | AB | 1 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A210221-002 | AB | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A210221-001 | AB | 1 | a67488948f0b… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A210221-002 | AB | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A210221-001 | AB | 1 | 3f0d92c62455… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A210221-002 | AB | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A210221-001 | AB | 1 | 053a50430f4f… |
| 2023-05-13 08:27 UTC | 2023-05 | A210221-002 | AB | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A210221-001 | AB | 1 | 3bdfa0b2c4d7… |
| 2023-01-26 05:58 UTC | 2023-01 | A210221-002 | AB | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A210221-001 | AB | 1 | 3a93d1ddd44b… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A210221-002 | AB | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A210221-001 | AB | 1 | f41ea6bd6efb… |
| 2022-10-28 04:53 UTC | 2022-10 | A210221-002 | AB | 1 | f41ea6bd6efb… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | 06c2fb2e-0539-4f16-bac4-e15a575ca802 | 2026-04-03 | Warnings, Adverse reactions | 210221 ANDA210221 63629-9206 |
| Cephalexin | CEPHALEXIN | Preferred Pharmaceuticlas Inc. | fbf5fcdf-40fc-40e5-b784-308032fff0e5 | 2026-03-25 | Warnings, Adverse reactions | 210221 ANDA210221 68788-7796 |
| Cephalexin | CEPHALEXIN | Preferred Pharmaceuticals, Inc. | 6c7bfa58-2d38-4607-8c33-485ba4931c68 | 2026-03-25 | Warnings, Adverse reactions | 210221 ANDA210221 68788-7529 |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | ee278959-d321-d356-e053-2995a90a32c2 | 2026-01-30 | Warnings, Adverse reactions | 210221 ANDA210221 68071-2889 |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | c7028200-b141-496b-89e9-491558d4c879 | 2025-11-10 | Warnings, Adverse reactions | 210221 ANDA210221 |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | 5f867aa3-ea64-4a14-a63b-979b8ff8d80c | 2025-11-07 | Warnings, Adverse reactions | 210221 ANDA210221 |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | 8d7f247a-3b42-4823-96fb-5f5c1bd94d49 | 2025-08-29 | Warnings, Adverse reactions | 210221 ANDA210221 63629-8857 |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | 1bfa8744-24ee-4c70-845c-c532b8084433 | 2025-07-29 | Warnings, Adverse reactions | 210221 ANDA210221 |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | a8f14231-5d43-46f7-ba1f-d6de8162d5e7 | 2024-11-20 | Warnings, Adverse reactions | 210221 ANDA210221 63629-9205 |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | e186afb5-7531-45ea-b785-c230483a7747 | 2024-08-20 | Warnings, Adverse reactions | 210221 ANDA210221 63629-9207 |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | f1439d25-3d3d-4fe5-b6e7-d76e62892969 | 2024-08-15 | Warnings, Adverse reactions | 210221 ANDA210221 |
| Cephalexin | CEPHALEXIN | A-S Medication Solutions | 28fec572-e3b9-448c-8626-5c0920f38eeb | 2024-07-30 | Warnings, Adverse reactions | 210221 ANDA210221 50090-4795 |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | df6bb893-e3d7-4c8f-8cec-35b4d2fa33b3 | 2024-07-26 | Warnings, Adverse reactions | 210221 ANDA210221 63629-8858 |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | f4ced8c7-a276-4a44-a60c-f8d1689a2bdf | 2024-07-26 | Warnings, Adverse reactions | 210221 ANDA210221 63629-9204 |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | ada33464-b416-9ac6-e053-2a95a90af787 | 2024-07-17 | Warnings, Adverse reactions | 210221 ANDA210221 68071-2246 |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | 90a76d24-e5a9-9000-e053-2a95a90ae8af | 2024-06-19 | Warnings, Adverse reactions | 210221 ANDA210221 68071-5038 |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | 92be9844-0775-4808-bdeb-dccb09647d91 | 2024-03-07 | Warnings, Adverse reactions | 210221 ANDA210221 |
| Cephalexin | CEPHALEXIN | A-S Medication Solutions | 0edeb103-5e94-4f42-828f-c7336486c784 | 2024-02-15 | Warnings, Adverse reactions | 210221 ANDA210221 50090-5196 |
| Cephalexin | CEPHALEXIN | Ascend Laboratories, LLC | bb28751c-bd1b-4e7f-8271-a14c1b4314e3 | 2022-07-07 | Warnings, Adverse reactions | 210221 ANDA210221 67877-544 67877-545 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 50090-4795 | Cephalexin | Cephalexin | A-S Medication Solutions | ANDA | Current |
| 50090-5196 | Cephalexin | Cephalexin | A-S Medication Solutions | ANDA | Current |
| 55700-841 | Cephalexin | Cephalexin | Quality Care Products, LLC | ANDA | Current |
| 55700-841 | Cephalexin | Cephalexin | Quality Care Products, LLC | ANDA | Current |
| 63629-8857 | Cephalexin | Cephalexin | Bryant Ranch Prepack | ANDA | Current |
| 63629-8857 | Cephalexin | Cephalexin | Bryant Ranch Prepack | ANDA | Current |
| 63629-8857 | Cephalexin | Cephalexin | Bryant Ranch Prepack | ANDA | Current |
| 63629-8858 | Cephalexin | Cephalexin | Bryant Ranch Prepack | ANDA | Current |
| 63629-8858 | Cephalexin | Cephalexin | Bryant Ranch Prepack | ANDA | Current |
| 63629-8858 | Cephalexin | Cephalexin | Bryant Ranch Prepack | ANDA | Current |
| 63629-9204 | Cephalexin | Cephalexin | Bryant Ranch Prepack | ANDA | Current |
| 63629-9204 | Cephalexin | Cephalexin | Bryant Ranch Prepack | ANDA | Current |
| 63629-9204 | Cephalexin | Cephalexin | Bryant Ranch Prepack | ANDA | Current |
| 63629-9205 | Cephalexin | Cephalexin | Bryant Ranch Prepack | ANDA | Current |
| 63629-9205 | Cephalexin | Cephalexin | Bryant Ranch Prepack | ANDA | Current |
| 63629-9205 | Cephalexin | Cephalexin | Bryant Ranch Prepack | ANDA | Current |
| 63629-9206 | Cephalexin | Cephalexin | Bryant Ranch Prepack | ANDA | Current |
| 63629-9206 | Cephalexin | Cephalexin | Bryant Ranch Prepack | ANDA | Current |
| 63629-9206 | Cephalexin | Cephalexin | Bryant Ranch Prepack | ANDA | Current |
| 63629-9207 | Cephalexin | Cephalexin | Bryant Ranch Prepack | ANDA | Current |
| 63629-9207 | Cephalexin | Cephalexin | Bryant Ranch Prepack | ANDA | Current |
| 63629-9207 | Cephalexin | Cephalexin | Bryant Ranch Prepack | ANDA | Current |
| 67877-544 | Cephalexin | Cephalexin | Ascend Laboratories, LLC | ANDA | Current |
| 67877-544 | Cephalexin | Cephalexin | Ascend Laboratories, LLC | ANDA | Current |
| 67877-545 | Cephalexin | Cephalexin | Ascend Laboratories, LLC | ANDA | Current |
| 67877-545 | Cephalexin | Cephalexin | Ascend Laboratories, LLC | ANDA | Current |
| 68071-2246 | Cephalexin | Cephalexin | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-2246 | Cephalexin | Cephalexin | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-2889 | Cephalexin | Cephalexin | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-5038 | Cephalexin | Cephalexin | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-5038 | Cephalexin | Cephalexin | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-5038 | Cephalexin | Cephalexin | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68788-7529 | Cephalexin | Cephalexin | Preferred Pharmaceuticals, Inc. | ANDA | Current |
| 68788-7529 | Cephalexin | Cephalexin | Preferred Pharmaceuticals, Inc. | ANDA | Current |
| 68788-7529 | Cephalexin | Cephalexin | Preferred Pharmaceuticals, Inc. | ANDA | Current |
| 68788-7796 | Cephalexin | Cephalexin | Preferred Pharmaceuticlas Inc. | ANDA | Current |
| 68788-7796 | Cephalexin | Cephalexin | Preferred Pharmaceuticlas Inc. | ANDA | Current |
| 68788-7796 | Cephalexin | Cephalexin | Preferred Pharmaceuticlas Inc. | ANDA | Current |